Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.

Autor: Ghaneh P; Department Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK. Electronic address: p.ghaneh@liverpool.ac.uk., Palmer D; Department Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK., Cicconi S; Department Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK; Swiss Tropical and Public Health Institute, Allschwil, Switzerland; Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland., Jackson R; Department Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK., Halloran CM; Department Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK., Rawcliffe C; Department Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK., Sripadam R; Clatterbridge Cancer Centre, Liverpool, UK., Mukherjee S; Oxford University Hospitals, Oxford, UK., Soonawalla Z; Oxford University Hospitals, Oxford, UK., Wadsley J; Weston Park Cancer Centre, Sheffield, UK., Al-Mukhtar A; Weston Park Cancer Centre, Sheffield, UK., Dickson E; Glasgow Royal Infirmary, Glasgow, UK., Graham J; Beatson West of Scotland Cancer Centre, Glasgow, UK., Jiao L; Hammersmith Hospital, London, UK., Wasan HS; Hammersmith Hospital, London, UK., Tait IS; Ninewells Hospital, Dundee, UK., Prachalias A; Guy's and St Thomas'Hospital, London, UK., Ross P; Guy's and St Thomas'Hospital, London, UK., Valle JW; University of Manchester, The Christie, Manchester, UK., O'Reilly DA; Manchester Royal Infirmary, Manchester, UK., Al-Sarireh B; Morriston Hospital, Swansea, UK., Gwynne S; Morriston Hospital, Swansea, UK., Ahmed I; Aberdeen Royal Infirmary, Aberdeen, UK., Connolly K; Aberdeen Royal Infirmary, Aberdeen, UK., Yim KL; Velindre Cancer Centre, Cardiff, UK., Cunningham D; Royal Marsden Hospital, London, UK., Armstrong T; Southampton General Hospital, Southampton, UK., Archer C; Southampton General Hospital, Southampton, UK., Roberts K; Queen Elisabeth Hospital, Birmingham, UK., Ma YT; Queen Elisabeth Hospital, Birmingham, UK., Springfeld C; University Hospital Heidelberg, Heidelberg, Germany., Tjaden C; University Hospital Heidelberg Department of Surgery, Heidelberg, Germany., Hackert T; University Hospital Heidelberg Department of Surgery, Heidelberg, Germany., Büchler MW; University Hospital Heidelberg Department of Surgery, Heidelberg, Germany., Neoptolemos JP; Department Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK; University Hospital Heidelberg Department of Surgery, Heidelberg, Germany.

Publikováno v: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2023 Feb; Vol. 8 (2), pp. 157-168. Date of Electronic Publication: 2022 Dec 12.

Nab-paclitaxel in combination with gemcitabine for the treatment of metastatic pancreas cancer: the South Wales experience.

Autor: Quinton AE; Wales Cancer Research Centre, Cardiff, UK.; Velindre Cancer Centre, Cardiff, UK., Gwynne SH; South West Wales Cancer Centre, Swansea, UK., Yim KL; Velindre Cancer Centre, Cardiff, UK. yimkl2000@hotmail.com.

Publikováno v: Medical oncology (Northwood, London, England) [Med Oncol] 2018 Jul 02; Vol. 35 (8), pp. 115. Date of Electronic Publication: 2018 Jul 02.

Assessment of gemcitabine, cisplatin and methylprednisolone (GEM-P) combination treatment for non-Hodgkin T cell lymphoma.

Autor: Yim KL; The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, London and Surrey, SM2 5PT, UK. yimkl2000@hotmail.com, Ashley S

Publikováno v: Medical oncology (Northwood, London, England) [Med Oncol] 2012 Dec; Vol. 29 (5), pp. 3535-9. Date of Electronic Publication: 2012 Jul 24.

Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome.

Autor: Yim KL; Gastrointestinal Cancer and Lymphoma Research Unit, The Royal Marsden NHS Foundation Trust, London and Surrey SM2 5PT, United Kingdom. yimkl2000@hotmail.com

Publikováno v: Medical oncology (Northwood, London, England) [Med Oncol] 2012 Sep; Vol. 29 (3), pp. 1796-801. Date of Electronic Publication: 2011 Sep 08.

Role of biological targeted therapies in gastroenteropancreatic neuroendocrine tumours.

Autor: Yim KL; Gastrointestinal Cancer and Lymphoma Research Unit, The Royal Marsden NHS Foundation Trust, London, Surrey, SM2 5PT, UK. yimkl2000@hotmail.com

Publikováno v: Endocrine [Endocrine] 2011 Oct; Vol. 40 (2), pp. 181-6. Date of Electronic Publication: 2011 Aug 26.